IL-23 gene expression in PBMCs of patients with coronary artery disease

Disease Markers

Volumn 33, Issue 6, 2012, Pages 289-293

  Khojasteh Fard, Maryam ^a,b   Abolhalaj, Milad ^a   Amiri, Parvin ^a   Zaki, Majid ^a   Taheri, Zahra ^a   Qorbani, Mostafa ^c   Bazzaz, Javad Tavakkoly ^b   Amoli, Mahsa M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAD; Cytokine; expression; gene; IL 23

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; INTERLEUKIN 17; INTERLEUKIN 23; RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84872290082     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-00933     Document Type: Article

References (19)

1. A.Tedgui, Z.Mallat, Cytokines in atherosclerosis: pathogenic and regulatory pathways, Physiol Rev 86 (2006); 515-581.
2. C. Weber, A. Zernecke, P. Libby, The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models, Nat Rev Immunol 8 (2008); 802-815.
3. G.K.Hansson, J.Nilsson, Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol 31 (2009); 95-101.
4. C. Lahoute, O. Herbin, Z. Mallat, A. Tedgui, Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets, Nat Rev Cardiol, (in press).
5. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: A comprehensive review of studies in mice, Cardiovascular Research 79 (2008); 360-376.
6. W. O'Connor, M. Kamanaka, C.J. Booth, T. Town, S. Nakae, Y. Iwakura, J.K. Kolls, R.A. Flavell, A protective function for interleukin 17A in T cell-mediated intestinal inflammation, Nat Immunol 10 (2009); 603-609.
7. J.K. Kolls, A. Linden, Interleukin-17 family members and inflammation, Immunity 21 (2004); 467-476.
8. T.A. Moseley, D.R. Haudenschild, L. Rose, A.H. Reddi, Interleukin-17 family and IL-17 receptors, Cytokine Growth Factor Rev 14 (2003); 155-174.
9. S. Antonopoulos, Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report, Circulation 106 (2002); 3143-421.
10. S. Chen, T.R. Crother, M. Arditi, Emerging role of IL-17 in atherosclerosis, J Innate Immun 2 (2010); 325-33.
11. S. Taleb, M. Romain, B. Ramkhelawon, C. Uyttenhove, G. Pasterkamp, O. Herbin, et al., Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis, J Exp Med 206 (2009); 2067-77.
12. T.van Es, G.H. van Puijvelde, O.H. Ramos, F.M. Segers, L.A. Joosten, W.B. van den Berg, et al. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice, Biochem Biophys Res Commun 388 (2009); 261-5.
13. C. Erbel, L. Chen, F. Bea, S. Wangler, S. Celik, F. Lasitschka et al., Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice, J Immunol 183 (2009); 8167-75.
14. V.S. Costa, T.C. Mattana, M.E. da Silva, Unregulated IL-23/IL-17 immune response in autoimmune diseases, Diabetes Res Clin Pract 88 (2010); 222-6.
15. R.L. Coffman, Origins of the T(H)1-T(H)2model: A personal perspective, Nat Immunol 7 (2006); 539-41.
16. A.N. Sieve, K.D. Meeks, S. Lee, R.E. Berg, A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production, Eur J Immunol 40 (2010); 2236-47.
17. A.B. Kulkarni, S. Karlsson, Transforming growth factor-beta-1 knockout mice-a mutation in one cytokine gene causes a dramatic inflammatory disease, Am J Pathol 143 (1993); 3-9.
18. M.M. Shull, I. Ormsby, A.B. Kier, Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease, Nature 359 (1992); 693-9.
19. M.O. Li, S. Sanjabi, R.A. Flavell, Transforming growth factorbeta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms, Immunity 25 (2006); 455-71.